Myeloma research group

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Hematology


  • myeloma, phagocyte, eosinophils, neutrophils , plasma cells, clinical trial



Our main aim is to improve outcome for the painful and fatal tumor disease, multiple myeloma (MM). To do this we pursue three lines of research; i) use investigator initiated clinical trials to test prevention strategies and ii) test new drug combinations in clinical trials and iii) investigate phagocyte subsets and functions during treatment and progression of MM.

Recent research outputs

Heaney, J. L. J., Richter, A., Bowcock, S., Pratt, G., Anthony Child, J., Jackson, G., Morgan, G., Ingemar Turesson & Drayson, M. T., 2020 Apr, In : Haematologica. 105, 4, p. E169-E171

Research output: Contribution to journalLetter

Petrus Linge, Sabine Arve, Olsson, L. M., Leonard, D., Sjöwall, C., Frodlund, M., Gunnarsson, I., Svenungsson, E., Helena Tydén, Andreas Jönsen, Robin Kahn, Johansson, Å., Rönnblom, L., Holmdahl, R. & Anders Bengtsson, 2020 Feb, In : Annals of the Rheumatic Diseases. 79, 2, p. 254-261 8 p.

Research output: Contribution to journalArticle

Maroulio Pertesi, Went, M., Markus Hansson, Kari Hemminki, Houlston, R. S. & Björn Nilsson, 2020 Jan 8, In : Leukemia.

Research output: Contribution to journalReview article

View All (28)